100 likes | 186 Views
This report from the Ottawa Group meeting discusses the new Medicine Price Index methodology introduced in 2006, focusing on its advantages and comparison with the former method. It highlights the importance of capturing price changes, especially for generic drugs, and the collaboration with the Swiss pharmacies association. The report also delves into the impact of substitution at different levels and outlines upcoming tasks for improving the index's quality, such as monthly data collection from 2008.
E N D
Experience with the new Medicine price Index Corinne Becker Vermeulen9-12 October 2007 : Ottawa Group meeting on Prices Ottawa
Contents • 1. Introduction • 2. Former and new method • 3. Comparison of results for 2005 and 2006 • 4. Substitution • 5. Upcoming tasks and conclusion
1. Introduction • Medicine prices subject to government authorization • Generic drugs more and more important • Pharmaceutical branch : « your index decreases too much ! » • Collaboration with the Swiss pharmacies association in order to better capture price changes • New method applied since the beginning of 2006
2. Former and new method • Advantages of the new method • Better market coverage • Recent data source • Greater accuracy • Substitution taken into account
4. Substitution • Taken into account at article and product type level • Better monitor price cuts and price increases
5. Upcoming tasks and conclusion • Monthly collection from 2008 (HICP) • Upgraded index quality